Yanna Zhang

Chengdu, 610072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Insulin gene-modified 3D stem cells for enhanced islet regeneration and systemic reversal of type 1 diabetes.

Insulin gene-modified 3D stem cells for enhanced islet regeneration and systemic reversal of type 1 diabetes.

Journal: Stem cells translational medicine

Published: October 17, 2025

ARNTL deregulation promotes ovarian cancer progression and metastasis by activating cancer-associated fibroblasts.

ARNTL deregulation promotes ovarian cancer progression and metastasis by activating cancer-associated fibroblasts.

Journal: Journal of ovarian research

Published: September 18, 2025

Targeting Myeloperoxidase in Disease Pathogenesis: Emerging Roles of Natural Products in Therapeutic Modulation.

Targeting Myeloperoxidase in Disease Pathogenesis: Emerging Roles of Natural Products in Therapeutic Modulation.

Journal: The American journal of Chinese medicine

Published: August 30, 2025

Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy.

Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy.

Journal: Translational oncology

Published: August 09, 2024

Circulating micronutrients levels and their association with the risk of endometriosis.

Circulating micronutrients levels and their association with the risk of endometriosis.

Journal: Frontiers in nutrition

Published: July 17, 2024

Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development.

Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: October 31, 2023

The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer.

The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer.

Journal: Scientific reports

Published: March 22, 2023

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis.

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis.

Journal: Frontiers in oncology

Published: November 20, 2021

Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective.

Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective.

Journal: Aging

Published: August 28, 2020

A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells.

A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells.

Journal: Oncotarget

Published: April 04, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026